Skip to main content
SpringerLink
Log in

Long-term benefits of induction therapy in NMO: a case report

  • Letter to the Editor
  • Published:
Neurological Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Pittock SJ, Lennon VA, Krecke K et al (2006) Brain abnormalities in neuromyelitis optica. Arch Neurol 63:390–396

    Article  PubMed  Google Scholar 

  2. Lennon VA, Wingerchuk DM, Kryzer TJ et al (2004) A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 364:2106–2112

    Article  CAS  PubMed  Google Scholar 

  3. Wingerchuk DM, Lennon VA, Pittock SJ et al (2006) Revised diagnostic criteria for neuromyelitis optica. Neurology 66:1485–1489

    Article  CAS  PubMed  Google Scholar 

  4. Weinstock-Guttman B, Ramanathan M, Lincoff N et al (2006) Study of mitoxantrone for the treatment of recurrent neuromyelitis optica (Devic disease). Arch Neurol 63:957–963

    Article  PubMed  Google Scholar 

  5. Pellfoker HL, Krumbholz M, Berthele A et al (2011) Long-term follow-up of patients with neuromyelitis optica after repeated therapy with rituximab. Neurology 76:1310–1315

    Article  Google Scholar 

  6. Cree BA, Lamb S, Morgan K et al (2005) An open label study of the effects of rituximab in neuromyelitis optica. Neurology 64:1270–1272

    Article  CAS  PubMed  Google Scholar 

  7. Jacob A, Weinshenker BG, Violich I et al (2008) Treatment of neuromyelitis optica with rituximab. Retrospective Analysis of 25 Patient. Arch Neurol 65:1443–1448

    Article  PubMed  Google Scholar 

  8. Jarius S, Aboul-Enein F, Waters P et al (2008) Antibody to aquaporin-4 in the long-term course of neuromyelitis optica. Brain 131:3072–3080

    Article  CAS  PubMed Central  PubMed  Google Scholar 

Download references

Conflict of interest

On behalf of all authors, the corresponding author states that there is no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Public Health, Clinical and Molecular Medicine, Multiple Sclerosis Center, University of Cagliari, Via Is Guadazzonis n. 2, 09126, Cagliari, Italy

    Jessica Frau, Giancarlo Coghe, Lorena Lorefice, Giuseppe Fenu & Eleonora Cocco

Authors
  1. Jessica Frau
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Giancarlo Coghe
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Lorena Lorefice
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Giuseppe Fenu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Eleonora Cocco
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jessica Frau.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Frau, J., Coghe, G., Lorefice, L. et al. Long-term benefits of induction therapy in NMO: a case report. Neurol Sci 35, 1831–1832 (2014). https://doi.org/10.1007/s10072-014-1830-5

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-014-1830-5

Keywords

Search

Navigation